Outcomes of Different Haploidentical Transplantation Strategies from the Taiwan Blood and Marrow Transplantation Registry
Journal
Cancers
Journal Volume
14
Journal Issue
4
Pages
1097
Date Issued
2022-02-21
Author(s)
Chen, Tzu-Ting
Gau, Jyh-Pyng
Wang, Po-Nan
Liu, Yi-Chang
Lien, Ming-Yu
Li, Chi-Cheng
Abstract
The two most noteworthy strategies for haploidentical stem cell transplantation (haplo-HSCT) are posttransplantation cyclophosphamide (PTCy) with or without thymoglobulin (ATG) and granulocyte colony stimulating factor-primed bone marrow plus peripheral blood stem cells (GIAC). We aimed to compare these approaches in patients with hematological malignancies.
Subjects
GIAC; PTCy; bone marrow stem cells; haploidentical; peripheral blood stem cells
SDGs
Publisher
MDPI
Type
journal article
